New Research Reports For Pepsi, Philips Morris & Dow Chemical
Zacks Investment Research | Oct 05, 2016 12:54AM ET
Wednesday, October 5, 2016
Today's Research Daily features new research reports on 16 major stocks, including Pepsi (PEP), Philip Morris (PM) and Dow Chemical (NYSE:DOW).
Buy rated Pepsi shares have benefited from the beverage giant's reported better-than-expected quarterly results last week, where it beat on the top- and bottom-lines and raised guidance. Drivng the momentum is the company's Frito-Lay North America and North American beverages businesses, but the company's new product line-up, aggressive marketing, productivity improvement and cost-saving initiatives are also helping. The company is on track to deliver $1 billion in productivity savings in 2016 and $7 billion in free cash flow. (You can )
Philip Morris shares have outperformed the peer group this year on the back of strong momentum in its unconventional tobacco products portfolio. The analyst likes the Buy-rated stock’s strong brand portfolio which is crucial in helping it command a leading market share in the tobacco industry. Additionally, the company's efforts to launch new products to cater to changing consumer tastes are also encouraging. The company has also done an excellent job of maintaining margins through effective cost controls despite continued volume pressures. (You can )
Dow Chemical shares have been laggards lately, reflecting global macro uncertainties about the economically sensitive chemicals space as a whole. Estimates have been moving up lately, largely reflecting improvements in productivity, aggressive portfolio management actions as well as strategic investments. This has pushed the stock to a Zacks Rank # 2 (Buy). The DuPont (NYSE:DD) merger is expected to create significant synergies and free cash flows in the long run. (You can )
Other noteworthy reports we are featuring today include Priceline (PCLN), Bank of America (NYSE:BAC) and 3M (MMM).
Today's Private Buys & Sells from Zacks Research
While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
You can find all of today's stock research reports >>>
Get The News You Want
Sheraz Mian
Director of Research
Note: If you want an email notification each time Sheraz publishes a new article, please >>>
Tuesday, October 4, 2016
Today's Research Daily features new research reports on 16 major stocks, including
Today's Must Read/h6
Featured Reports/h6
The Zacks analyst believes that Agilent's broad-based portfolio and innovative high-margin products offer higher growth potential.
The covering analyst believes HCP's diversified, high-quality and well-balanced portfolios allows it to explore the opportunities available in various areas, based on individual market dynamics.
The Zacks analyst appreciates EOG Resources' decision to buy Yates Petroleum as the deal will add quality acreage in the Delaware and Powder River basins.
The covering analyst thinks 3M remains vulnerable to risks related to high pension expenses, commodity price volatility and U.S. dollar strength.
The Zacks analyst believes that weaker ADR, increasing advertising spend and occupancy tax-related litigation remain overhangs.
The covering analyst believes that Valero's $2.6 billion investment plan for this year will help it to significantly improve its operations.
The Zacks analyst thinks Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, and strong specialty growth.
The Zacks analyst believes that Agilent's broad-based portfolio and innovative high-margin products offer higher growth potential.
The covering analyst believes HCP's diversified, high-quality and well-balanced portfolios allows it to explore the opportunities available in various areas, based on individual market dynamics.
The Zacks analyst appreciates EOG Resources' decision to buy Yates Petroleum as the deal will add quality acreage in the Delaware and Powder River basins.
The covering analyst thinks 3M remains vulnerable to risks related to high pension expenses, commodity price volatility and U.S. dollar strength.
The Zacks analyst believes that weaker ADR, increasing advertising spend and occupancy tax-related litigation remain overhangs.
The covering analyst believes that Valero's $2.6 billion investment plan for this year will help it to significantly improve its operations.
The Zacks analyst thinks Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, and strong specialty growth.
New Upgrades/h6
Cintas recorded solid 1Q results with adjusted earnings beating the Zacks Consensus Estimate by $0.03. The accretive acquisition of G&K Services and bullish fiscal 2017 guidance remain tailwinds.
ConAgra's robust first-quarter fiscal 2017 earnings were driven by restructuring benefits. The company aims to divest the Lamb Weston trade by fiscal 2017-end and form two separate public companies.
The Zacks analyst believes that Analog Devices' strength in the emerging automotive market and Linear acquisition remain growth catalysts going forward.
Cintas recorded solid 1Q results with adjusted earnings beating the Zacks Consensus Estimate by $0.03. The accretive acquisition of G&K Services and bullish fiscal 2017 guidance remain tailwinds.
ConAgra's robust first-quarter fiscal 2017 earnings were driven by restructuring benefits. The company aims to divest the Lamb Weston trade by fiscal 2017-end and form two separate public companies.
The Zacks analyst believes that Analog Devices' strength in the emerging automotive market and Linear acquisition remain growth catalysts going forward.
New Downgrades/h6
The Zacks analyst notes that unfavorable currency and lower volumes in North America and Europe continue to affect Diageo. Restrictions on alcohol consumption across the world have also hurt revenues.
The covering analyst believes that without any further rise in interest rates, BofA's margins are likely to remain under pressure. Also, stressed energy sector will hurt its financials in near-term.
The covering analyst has turned bearish on Energy Transfer Partners considering its lofty yield and concerns over the partnership's ability to maintain current distribution.
The Zacks analyst notes that unfavorable currency and lower volumes in North America and Europe continue to affect Diageo. Restrictions on alcohol consumption across the world have also hurt revenues.
The covering analyst believes that without any further rise in interest rates, BofA's margins are likely to remain under pressure. Also, stressed energy sector will hurt its financials in near-term.
The covering analyst has turned bearish on Energy Transfer Partners considering its lofty yield and concerns over the partnership's ability to maintain current distribution.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.